by The global remote patient monitoring system market size was valued at USD 1,280.0 million in 2021, and is predicted to be worth around USD 5.7 billion by 2030, registering a CAGR of 20.1% during the forecast period 2022 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39198
Table of Contents
Remote Patient Monitoring System Market Growth Factors
COVID-19 pandemic has a significant impact on the remote patient monitoring system. The main drivers for this market are the increasing geriatric population, cost-effective treatment, and the rising prevalence of chronic conditions. The breakout of Covid-19 has propelled the demand for remote patient monitoring devices and services as healthcare facilities were burdened with Covid-19 infected patients. Key players like Smiths Medical reported that the demand of their home monitoring devices substantially increased during the pandemic.
The amalgamation of telehealth with remote patient monitoring services is expected to further boost market growth. Asia Pacific is also projected to be a key revenue generator in the coming years. The region is backed by developing countries such as China, South Korea, and Thailand which are witnessing an increase in the number of chronic diseases owing to lifestyle changes.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 5.7 billion by 2030 |
| Growth Rate | CAGR of 20.1% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Nihon Kohden Corporation; Omron Corporation; OSI Systems, Inc.; Koninklijke Philips N.V.; F. Hoffmann-La Roche Ltd; Welch Allyn; Smiths Medical; Abbott; Boston Scientific Corporation; Dräger Medical; GE Healthcare; Honeywell; Johnson & Johnson; LifeWatch; Medtronic; Masimo; Vitls, Inc.; CareValidate; Biotronik; American Telecare |
By Product Analysis
The vital sign monitors are commonly used, and the segment is expected to witness the fastest growth rate of 21.9% in the market for remote patient monitoring system over the forecast period. Heart rate monitor is identified as the dominating product sub-segment due to the increasing incidence of cardiac conditions globally. The surge in the number of individuals with heart disorders has led to the increased usage of these monitors.
The surge in the number of individuals with heart disorders has led to the increased usage of these monitors. In 2019, Withings introduced the most advanced and diverse home cardiovascular monitors at CES. It is expected to be the first product that measures BP and records ECG and heart readings via a digital stethoscope in one device.
By Application Analysis
Diabetes emerged as the leading application segment in 2021 and accounted for over 12.8% of the revenue share. Diabetes is one of the leading causes of death, which requires continuous monitoring of blood glucose levels. It is known to affect various functions of the body including heart activity, vision, liver function, and renal activity.
The hypertension application segment is also expected to witness significant growth over the forecast period. Hypertension increases the risk of cardiovascular diseases. According to the World Health Organization (WHO), over 1.0 billion people have hypertension worldwide.
By End-use Analysis
The hospital-based patient segment was the leading end-use segment in 2021 and accounted for 79.4% of the revenue share. Hospitals cater to a large number of outpatients as well as inpatients. They offer a large number of diagnostic tests and have a larger technical staff for catering to the needs of the patients.
A large patient pool and an increasing number of tests being performed are the vital drivers for segment growth. Hospital patients are admitted to facilities in need of acute care and therefore it is vital to keep a continuous check on the vital parameters of patients.
The cost-efficiency of this alternate site along with the availability of qualified resources is expected to support the growth. In addition, considering the increasing strain on hospital resources and personnel, remote patient monitoring presents market players with huge opportunities in terms of partnering with hospitals and other healthcare settings and launching new products to facilitate affordable care at a patient’s home.
By Regional Analysis
North America dominated the remote patient monitoring system market and accounted for the largest revenue share of 41.6% in 2021. The increase in the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of sophisticated reimbursement structures aimed at cutting out-of-pocket expenditure are the major factors attributed to the regional growth.
In Asia Pacific, the market is expected to witness the fastest CAGR over the forecast period owing to the presence of untapped opportunities in the emerging markets of India and China. Japan is expected to be a key revenue generator owing to its wide old age (65+) population.
Read also @ Cosmetic Surgery And Procedure Market Impressive Gains by 2022-2030
Major Key Players Covered in The Remote Patient Monitoring System Market Report include
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Nihon Kohden Corporation
- Omron Corporation
- OSI Systems, Inc.
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd
- Welch Allyn
- Smiths Medical
- Abbott
- Boston Scientific Corporation
- Dräger Medical
- GE Healthcare
- Honeywell
- Johnson & Johnson
- LifeWatch
- Medtronic
- Masimo
- Vitls, Inc
- CareValidate
- Biotronik
- American Telecare
Remote Patient Monitoring System Market Segmentation
- By Product
- Vital Sign Monitors
- Blood Pressure Monitors
- Pulse Oximeters
- Heart Rate Monitor (ECG)
- Temperature Monitor
- Respiratory Rate Monitor
- Brain Monitoring (EEG)
- Special Monitors
- Anesthesia Monitors
- Blood Glucose Monitors
- Cardiac Rhythm Monitor
- Respiratory Monitor
- Fetal Heart Monitors
- Prothrombin Monitors
- Multi-Parameter Monitors (MPM)
- Others
- Vital Sign Monitors
- By Application
- Cancer
- Cardiovascular Diseases
- Diabetes
- Sleep Disorder
- Weight management and Fitness Monitoring
- Bronchitis
- Infections
- Virus
- Dehydration
- Hypertension
- By End-use
- Hospital Based Patients
- Ambulatory Patients
- Home Healthcare
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- MEA
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Remote Patient Monitoring System Market, By Product
7.1. Remote Patient Monitoring System Market, by Product, 2021-2030
7.1.1. Vital Sign Monitors
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Special Monitors
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Remote Patient Monitoring System Market, By Application
8.1. Remote Patient Monitoring System Market, by Application, 2021-2030
8.1.1. Cancer
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Cardiovascular Diseases
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Diabetes
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Sleep Disorder
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Weight management and Fitness Monitoring
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Bronchitis
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Infections
8.1.7.1. Market Revenue and Forecast (2019-2030)
8.1.8. Virus
8.1.8.1. Market Revenue and Forecast (2019-2030)
8.1.9. Dehydration
8.1.9.1. Market Revenue and Forecast (2019-2030)
8.1.10. Hypertension
8.1.10.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Remote Patient Monitoring System Market, By End User
9.1. Remote Patient Monitoring System Market, by End User, 2021-2030
9.1.1. Hospital Based Patients
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Ambulatory Patients
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Remote Patient Monitoring System Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by End User (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 11. Company Profiles
11.1. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Nihon Kohden Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Omron Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. OSI Systems, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Koninklijke Philips N.V.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. F. Hoffmann-La Roche Ltd
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Welch Allyn
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Smiths Medical
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Abbott
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Boston Scientific Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39198
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
